Detection of Macrophages in Aortic Aneurysms by Nanoparticle Positron Emission Tomography–Computed Tomography

Objective—Current management of aortic aneurysms (AAs) relies primarily on size criteria to determine whether invasive repair is indicated to preempt rupture. We hypothesized that emerging molecular imaging tools could be used to more sensitively gauge local inflammation. Because macrophages are key effector cells that destabilize the extracellular matrix in the arterial wall, it seemed likely that they would represent suitable imaging targets. We here aimed to develop and validate macrophage-targeted nanoparticles labeled with fluorine-18 (18F) for positron emission tomography–computed tomography (PET-CT) detection of inflammation in AAs. Methods and Results—Aneurysms were induced in apolipoprotein E−/− mice via systemic administration of angiotensin II. Mice were imaged using PET-CT and a monocyte/macrophage–targeted nanoparticle. AAs were detected by contrast-enhanced micro-CT and had a mean diameter of 1.85±0.08 mm, whereas normal aortas measured 1.07±0.03 (P<0.05). The in vivo PET signal was significantly higher in aneurysms (standard uptake value, 2.46±0.48) compared with wild-type aorta (0.82±0.05, P<0.05). Validation with scintillation counting, autoradiography, fluorescence, and immunoreactive histology and flow cytometry demonstrated that nanoparticles localized predominantly to monocytes and macrophages within the aneurysmatic wall. Conclusion—PET-CT imaging with 18F-labeled nanoparticles allows quantitation of macrophage content in a mouse model of AA.

[1]  M J Davies,et al.  Aortic aneurysm formation: lessons from human studies and experimental models. , 1998, Circulation.

[2]  A Daugherty,et al.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.

[3]  D Bergqvist,et al.  Literature review of surgical management of abdominal aortic aneurysm. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  D. C. Brewster,et al.  Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. , 2003, Journal of vascular surgery.

[5]  R. Weissleder,et al.  Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.

[6]  Rodney A. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[7]  A. Daugherty,et al.  Role of the Renin‐Angiotensin System in the Development of Abdominal Aortic Aneurysms in Animals and Humans , 2006, Annals of the New York Academy of Sciences.

[8]  Peter Libby,et al.  Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[9]  Rodney A. White,et al.  ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent , 2006, Journal of vascular and interventional radiology : JVIR.

[10]  R. Charnigo,et al.  Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. , 2006, Journal of vascular surgery.

[11]  S. Muluk,et al.  A decade of change in abdominal aortic aneurysm repair in the United States: Have we improved outcomes equally between men and women? , 2006, Journal of vascular surgery.

[12]  P. Libby,et al.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions , 2007, The Journal of experimental medicine.

[13]  B. Krause,et al.  Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. , 2008, Journal of vascular surgery.

[14]  Zahi A. Fayad,et al.  Imaging of atherosclerotic cardiovascular disease , 2008, Nature.

[15]  W. Oyen,et al.  In Vivo Imaging of Abdominal Aortic Aneurysms: Increased FDG Uptake Suggests Inflammation in the Aneurysm Wall , 2008, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[16]  F. Epstein,et al.  Multimodality cardiovascular molecular imaging, part I. , 2008, Circulation. Cardiovascular imaging.

[17]  Martin Gotthardt,et al.  Spatial Resolution and Sensitivity of the Inveon Small-Animal PET Scanner , 2008, Journal of Nuclear Medicine.

[18]  D. Kraitchman,et al.  Advances in Cardiovascular Imaging Multimodality Cardiovascular Molecular Imaging, Part II , 2008 .

[19]  W. Buurman,et al.  Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation , 2009, Nature Reviews Cardiology.

[20]  Elliot L Chaikof,et al.  The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. , 2009, Journal of vascular surgery.

[21]  Gregory J. Hardy,et al.  Interferon- (cid:1) and the Interferon-Inducible Chemokine CXCL10 Protect Against Aneurysm Formation and Rupture Molecular Cardiology , 2009 .

[22]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[23]  D. Milewicz,et al.  An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. , 2009, The Journal of clinical investigation.

[24]  M. McConnell,et al.  Analysis of In Situ and Ex Vivo Vascular Endothelial Growth Factor Receptor Expression During Experimental Aortic Aneurysm Progression , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[25]  Greg M Thurber,et al.  18F labeled nanoparticles for in vivo PET-CT imaging. , 2009, Bioconjugate chemistry.

[26]  X. Y. Xu,et al.  Response to Comment on High Levels of 18F-FG Uptake in Aortic Aneurysm Wall are Associated with High Wall Stress , 2010 .

[27]  R. Weissleder,et al.  Angiotensin-Converting Enzyme Inhibition Prevents the Release of Monocytes From Their Splenic Reservoir in Mice With Myocardial Infarction , 2010, Circulation research.

[28]  M. Watkins.  TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II–infused mice , 2010 .

[29]  L. Rénia,et al.  TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. , 2010, The Journal of clinical investigation.

[30]  X. Y. Xu,et al.  High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[31]  R. Weissleder,et al.  Hybrid PET-optical imaging using targeted probes , 2010, Proceedings of the National Academy of Sciences.

[32]  M. Pittet,et al.  Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. , 2010, Circulation.